Loading...
Tocilizumab improved clinical symptoms of a patient with systemic tophaceous gout who had symmetric polyarthritis and fever: An alternative treatment by blockade of interleukin-6 signaling
Chronic tophaceous gout is the end stage of gout. We employed a blockade of interleukin-6 signaling therapy by tocilizumab instead of anakinra, an interleukin-1 receptor antagonist, for a 61-year-old Japanese woman diagnosed with tophaceous gout. Laboratory data showed that serum interleukin-6 conce...
Na minha lista:
| Udgivet i: | SAGE Open Med Case Rep |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4857353/ https://ncbi.nlm.nih.gov/pubmed/27489636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X13519774 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|